News

(RTTNews) - Orthofix Medical Inc. (OFIX) announced preliminary fourth quarter net sales of approximately $200.3 million, an increase of 63.8% on a reported basis and 62.8% on a constant currency basis from fourth quarter 2022. For the full year 2023, preliminary net sales were approximately $746.5 million, an increase of 62.0% on a reported basis and 61.5% on a constant currency basis.

Catherine Burzik, Chair of the Board and former Interim CEO of Orthofix, said: "Our preliminary revenue numbers reflect heightened performance and increased momentum across all business segments."

Orthofix and SeaSpine merged in January 2023 to form a global spine and orthopedics company.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.